About
Team
Product Objective
Newsroom
Investment Opportunity
Pet-Owner Stories
Disclaimer
About
Team
Product Objective
Newsroom
Investment Opportunity
Pet-Owner Stories
Disclaimer
Rescuing Canines from Breakthrough Seizures
Newsroom
January 2023
Epilepsy Update
November 2022
MesaGreen Pharmaceutical Company Files an Investigational New Animal Drug Application
January 2022
Mesa Green Canine Study Results Reported at Epilepsy Conference
September 2021
MesaGreen Receives Positive Feedback from FDA’s Center for Veterinary Medicine
April 2021
MesaGreen Shows Progress and Promise Moving Forward
October 2020
Research Study Expanded
November 2019
Results Evaluated
Octoer 2019
Research Study Initiated
August 2019
MesaGreen K9MGP Seizure Program
